Table 1. Data on the Compounds Analyzed in This Study.

n	name	MW	main target	used for	KI CA II (nM)
1	Celecoxib	381.4	COX-2	inflammation, pain	21
2	Valdecoxib	314.4	COX-2	inflammation, pain	43
3	Indapamide	362.8	Na/Cl cotransporter	hypertension, heart failure	2520
4	Furosemide	330.7	Na/K/Cl cotransporter	hypertension, heart failure, edema	65
5	Hydrochlorothiazide	297.7	Na/Cl cotransporter	hypertension, heart failure, edema, diabetes insipidus	290
6	Zonisamide	212.2	Sodium and T-type calcium channels (putative)	epilepsy, Parkinson’s disease	35
7	Ethoxzolamide	258.3	CA	glaucoma, duodenal ulcers	8
8	SLC-0111	309.3	CA	tumor	960
9	Methazolamide	236.3	CA	glaucoma	14